Generation of highly variably AAV capsid libraries using a novel DNA shuffling platform

被引：0
|
作者：
Cabanes-Creus, M. [1 ,2 ,3 ]
Filip, A. [1 ]
Liao, S. H. Y. [1 ]
Ward, J. [1 ]
Ginn, S. L. [1 ]
Santilli, G. [2 ,3 ]
Thrasher, A. J. [2 ,3 ]
Alexander, I. E. [1 ,4 ]
Lisowski, L. [1 ,5 ]
机构：
[1] Childrens Med Res Inst, London, England
[2] Inst Child Hlth, London, England
[3] UCL, London, England
[4] Univ Sydney, Sydney, NSW, Australia
[5] Mil Inst Hyg & Epidemiol, Warsaw, Poland
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
OR24
引用
收藏
页码：A9 / A10
页数：2
相关论文
共 50 条
  • [41] Manufacturability and Product Quality of Novel AAV Capsids Optimized for Specific Targeting Using Capsid Library Selection in Non-Human Primates
    Acharya, Hari
    Chu, David
    Cockrell, Adam
    Granados, Jesse
    Liu, Carol
    Mitchell, Alex
    Morales, Heidy
    Pedeferri, Carrie
    Rodden, Jenna
    Sandberg, Troy
    Simington, Claire
    Springfield, Emily
    Wheeler, Brandon
    Wheeler, Jordyn
    Goeden, Nick
    Adamson, Laura
    MOLECULAR THERAPY, 2022, 30 (04) : 534 - 534
  • [42] Splicing is improved using a novel AAV-microRNA delivery platform as a treatment for myotonic dystrophy type 1
    Cao, S.
    Tomassy, G.
    Richards, B.
    Fan, W.
    Luo, Z.
    Jackson, R.
    O'Riordan, C.
    Goulet, M.
    Mueller, C.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [43] Rapid and highly-specific generation of targeted DNA sequencing libraries enabled by linking capture probes with universal primers
    Pel, Joel
    Leung, Amy
    Choi, Wendy W. Y.
    Despotovic, Milenko
    Ung, W. Lloyd
    Shibahara, Gosuke
    Gelinas, Laura
    Marziali, Andre
    PLOS ONE, 2018, 13 (12):
  • [44] Creating next-generation biologics using a novel chemistry platform technology
    Pattabiraman, Vijaya R.
    Ruiz, Matilde Arevalo
    Boehringer, Regis
    Hornsperger, Benoit
    Meoded, Roy
    Tam, Robert C.
    Kreft, Bertolt
    CANCER RESEARCH, 2022, 82 (12)
  • [45] Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors (vol 8, e62097, 2013)
    Kay, C. N.
    Ryals, R. C.
    Aslanidi, G., V
    Min, S. H.
    Ruan, Q.
    PLOS ONE, 2014, 9 (09):
  • [46] Reduction of Atxn2, a Therapeutic Target for Sporadic ALS, in Non-Human Primates Using a Novel, Intravenously Delivered AAV Capsid
    Murlidharan, Giridhar
    Grandell, Emily
    Janack, Stephen
    Berry, Amanda
    Guelin, Isabelle
    Gualtieri, Charles
    Ironside, Tyler
    Scott, Elizabeth
    Pryce, Cynthia
    Mastis, Bryan
    Sami, Ramin Kamran
    Edwards, Matt
    Reece-Hoyes, John
    West, Cara
    Calcedo, Roberto
    Goswami, Dharmendra
    Cao, Sherry
    Stanek, Lisa M.
    Lilley, Graham
    Richman, Laura K.
    Albright, Charles F.
    MOLECULAR THERAPY, 2024, 32 (04) : 162 - 162
  • [47] A novel approach to gene therapy for methylmalonic acidemia using an ancestral AAV capsid and synthetic vaccine particles containing rapamycin (SVP-R)
    Venditti, Charles P.
    Chandler, Randy J.
    Li, Lina
    Andres-Mateos, Eva
    Xiao, Ru
    Ilyinskii, Petr
    Vandenberghe, Luk
    Kishimoto, Takashi Kei
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (03) : 273 - 273
  • [48] Generation of isogenic allelic series of LMNA-mutated hiPSC lines using the novel and highly-efficient targeting platform, STRAIGHT-IN
    Meraviglia, V
    Blanch-Asensio, A.
    Davis, R.
    Mummery, C. L.
    Bellin, M.
    CARDIOVASCULAR RESEARCH, 2024, 120
  • [49] Generation of novel DNA-binding compounds by selection and amplification from self-assembled combinatorial libraries
    Klekota, B
    Hammond, MH
    Miller, BL
    TETRAHEDRON LETTERS, 1997, 38 (50) : 8639 - 8642
  • [50] GENERATION OF A HIGHLY POTENT, CIS-SIGNALING PD1-IL2 IMMUNOCYTOKINE USING A NOVEL CHEMICAL SYNTHESIS AND CONJUGATION PLATFORM
    Carralot, Jean
    Ruiz, Matilde Arevalo
    Sanchez, Ruben Alvarez
    Tam, Robert
    Gremlich, Lilian
    Chi, Andrew
    Kreft, Vijaya Pattabiraman Bertolt
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1239 - A1239
12345